PI3Kδ activation, IL-6 overexpression, and CD37 loss cause resistance to naratuximab emtansine in lymphomas
Titel:
PI3Kδ activation, IL-6 overexpression, and CD37 loss cause resistance to naratuximab emtansine in lymphomas
Auteur:
Arribas, Alberto J. Napoli, Sara Gaudio, Eugenio Herbaux, Charles Cannas, Eleonora Tarantelli, Chiara Bordone-Pittau, Roberta Cascione, Luciano Munz, Nicolas Aresu, Luca Sgrignani, Jacopo Rinaldi, Andrea Kwee, Ivo Rossi, Davide Cavalli, Andrea Zucca, Emanuele Stussi, Georg Stathis, Anastasios Sloss, Callum Davids, Matthew S. Bertoni, Francesco